american diabetes association 'history of pancreatitis' glp-1 receptor agonist pancreatitis history GLP-1 receptor agonism: a transformative approach Glucagon-like Peptide 1 Receptor Signaling

As MBS leaderand Accomplish Health advisorJOHN MORTON puts it: Combining surgical approaches and GLP-1 receptor agonist therapy presents an opportunity to further improve outcomes for patients undergoing MBS. --- Review: Combining Medications With Bariatric Surgery to Treat Obesity To view or add a comment, sign in Compared with GLP-1 RAs, bariatric metabolic surgery was associated with lower rates of: All-cause mortality Major adverse cardiovascular events (MACE) Nephropathy Retinopathy These findings indicate that even with the availability of GLP-1 RAs, metabolic surgery remains superior to medical treatment for macrovascular and microvascular outcomes in patients with diabetes and obesity

Common side effects include nausea, vomiting, and diarrhea, but they are generally well-tolerated and tend to improve over time

Our compounded medications are not affiliated with, nor endorsed by, Eli Lilly or Novo Nordisk, and are not reviewed by the FDA for safety or efficacy

Centre for Women's Health and Fertility, India Poli Mara Spritzer, Federal University of Rio Grande Do Sul, Brazil Elisabet Stener-Victorin, Karolinska Institutet, Sweden Fahimeh Ramezani Tehrani, Shahid Beheshti University of Medical Sciences, Iran Shakila Thangaratinam, University of Birmingham, UK Mala Thondan, Harp Family Medical, Australia Eszter Vanky, Norwegian University of Science and Technology

Lets build a benefit model that worksfor your clients, your employees, and your bottom line

doi: 10.1210/jc.2017-01949 29 BergmannNCLundAGasbjergLSJrgensenNRJessenLHartmannBet al